Gilde Healthcare strengthens US Venture&Growth team with Rich Wilmot as partner - Gilde Healthcare

Gilde Healthcare strengthens US Venture&Growth team with Rich Wilmot as partner

8. Juni 2023
Boston, MA (US)

Gilde Healthcare, a leading transatlantic investment firm specialized in the healthcare sector, today announced the appointment of Rich Wilmot as a Partner in its US Venture&Growth team. Mr. Wilmot brings over 15 years of experience in digital health and healthtech investing to the firm.

Wilmot’s appointment comes at an exciting time as Gilde Healthcare continues to expand its presence in the US market and to strengthen its investment capabilities in the rapidly evolving healthcare landscape. As a Partner, Mr. Wilmot will play an important role in driving Gilde Healthcare’s investment strategy and furthering its mission to deliver better care at lower cost.

“We are thrilled to welcome Rich Wilmot to our US team as a Partner,” said Geoff Pardo, General Partner at Gilde Healthcare. “His extensive experience and deep understanding of healthcare delivery, digital health and the wider healthtech sector make him an important addition to our firm. Rich’s strategic vision and proven track record of successful investments will greatly contribute to our mission of driving innovation and improving patient outcomes.”

Prior to joining Gilde Healthcare, Mr. Wilmot was responsible for creating and managing the corporate venture program at Philips, where he built an industry leading portfolio, investing in many companies during his seven years of leadership. Prior to joining Philips, Mr. Wilmot spent five years at Partners HealthCare investing in healthtech companies. His expertise spans all key areas of digital innovation in the healthcare industry including the areas of telemedicine, healthcare analytics, remote patient monitoring and digital therapeutics.

“I am excited to join Gilde Healthcare and work alongside a team of highly skilled professionals who are committed to making a difference in the healthcare industry,” said Wilmot. “Gilde Healthcare’s dedication to investing in companies that drive positive change aligns perfectly with my passion for advancing healthcare through innovative solutions. I look forward to contributing to the firm’s continued success and impact.”

Wilmot’s appointment reinforces Gilde Healthcare’s commitment to attracting top talent and further strengthens its ability to identify and support promising investment opportunities in the US market. With his profound knowledge and extensive network, Mr. Wilmot will enhance the firm’s capabilities in identifying disruptive companies and partnering with visionary entrepreneurs.

Media contact:
Geoff Pardo – General Partner Gilde Healthcare US
email: pardo@gildehealthcare.com
phone: +1 (617) 407 4865

Pieter van der Meer – Managing Partner Gilde Healthcare
email: vandermeer@gildehealthcare.com
phone: +31 30 219 2565

About Gilde Healthcare
Gilde Healthcare is a specialized healthcare investor managing over €2.5 billion across two fund strategies: Venture&Growth and Private Equity. The Venture&Growth fund of Gilde Healthcare invests in fast growing companies active in digital health, medtech and therapeutics, based in Europe and North America. The Private Equity fund of Gilde Healthcare participates in profitable lower mid-market healthcare companies based in North-Western Europe. For more information, visit the company’s website at www.gildehealthcare.com.

Gilde Healthcare participates in $150M Series D financing of CatalYm

Proceeds will expand late-stage clinical development of lead programme visugromab’s into earlier lines of treatment including checkpoint naïve and second-line settings in randomized, controlled studies in select solid tumor indications Round brings on board new international...
16. Juli 2024

Gilde Healthcare portfolio company Eetgemak joins forces with TotaalVERS to become the leading integrated healthcare foodservice provider

Combining TotaalVERS and Eetgemak will form a leading end-to-end foodservice provider*, offering a wide range of convenience meals, ingredients and groceries to the healthcare sector. The partnership emphasizes commitment to quality, service, and innovation in...
5. Juli 2024

Gilde Healthcare company Volta Medical announces positive results from transatlantic trial on AI-assisted ablation for persistent atrial fibrillation

TAILORED-AF randomized controlled trial (RCT) findings demonstrated superiority in freedom from atrial fibrillation (AF) at 12 months from a tailored cardiac ablation guided by artificial intelligence (AI) when compared to pulmonary vein isolation (PVI) alone....
21. Mai 2024